Medicinova MNOV
NASDAQ MNOV
$1.40 -0.07 (-4.76%)
At close: Nov 10, 2026 · 4:00 PM EST

Medicinova (MNOV) EBITDA Margin (2012 - 2026)

Updated

Medicinova (MNOV) posted EBITDA Margin of -2034.97% for Q4 2025, up 702.40 percentage points from the prior quarter.

Analysis

Medicinova (MNOV) EBITDA Margin (2012 - 2026) Analysis & Trends

For FY2025, Medicinova's EBITDA Margin came in at -3237.56%.

  • Annual EBITDA Margin shows a four-year change of -2985.19 percentage points (FY2021 to FY2025).
  • In prior years, Medicinova's EBITDA Margin was -988.00% in FY2023 and -252.38% in FY2021.
  • The Q4 2025 figure stands as the highest quarterly EBITDA Margin since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 54.65%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 32.68%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 46.88%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 40.75%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 46.62%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 50.63%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 42.49%
10 Medicinova 71.62 Mn -44.53 Mn - -553.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -553.22%
Mar 31, 2026 -1,514.33%
Dec 31, 2025 -2,034.97%
Sep 30, 2025 -2,737.37%
Jun 30, 2025 -2,676.12%
Sep 30, 2023 -114.12%
Sep 30, 2021 -9,586.06%
Mar 31, 2021 -4.88%
Dec 31, 2013 57.28%
Jun 30, 2013 -1,071,782.88%
Mar 31, 2013 -79,457.57%
Dec 31, 2012 -7,021.10%
Sep 30, 2012 -2,790.17%
Jun 30, 2012 -461.66%
Mar 31, 2012 -2,023.20%
API Access

Medicinova EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MNOV&period=max&api_key=YOUR_API_KEY